Rovanersen
DC47310
View product →
Inclisiran (ALN-PCSsc) is a double-stranded small interfering RNA (siRNA) molecule that inhibits the transcription of PCSK-9. Inclisiran can be used for hyperlipidemia and cardiovascular disease (CVD) research.
| CAS No. | 1639324-58-5 |
| Chemical Name | Inclisiran |
| Synonyms | CQQ59545BV;Cemdisiran;Inclisiran;ALN-PCSsc;Cemdisiran, terminal sugar modification-;Inclisiran, terminal sugar modification- |
| SMILES | P(=O)(O)(O)OC[C@@H]1C[C@H](CN1C(CCCCCCCCCCC(NC(COCCC(NCCCNC(CCCCO[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)NC(C)=O)=O)=O)(COCCC(NCCCNC(CCCCO[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)NC(C)=O)=O)=O)COCCC(NCCCNC(CCCCO[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)NC(C)=O)=O)=O)=O)=O)O |
| Formula | C78H140N11O34P |
| M.Wt | 1806.97328567505 |
| Purity | >95% |
| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Shipping condition | Ships from Shanghai; packaging confirmed at order. |
| Publication | Not available |
| Product classification | siRNA/ASOs/Aptamer drugs |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 5.5341 mL | 1.1068 mL | 0.5534 mL |
| 25 mg | 13.8353 mL | 2.7671 mL | 1.3835 mL |
| 50 mg | 27.6706 mL | 5.5341 mL | 2.7671 mL |
| 100 mg | 55.3412 mL | 11.0682 mL | 5.5341 mL |
| 250 mg | 138.3529 mL | 27.6706 mL | 13.8353 mL |
Contact our team with the catalog number and requested quantity.